Squarepoint Ops LLC Orchard Therapeutics PLC Transaction History

Squarepoint Ops LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.7 - $1.51 $10,318 - $22,257	-14,740 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $21,216 - $40,786	-18,290 Reduced 55.37%	14,740 $19,000
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $29,191 - $55,907	13,032 Added 65.17%	33,030 $76,000
Q2 2021 Aug 16, 2021	SELL	$4.39 - $7.23 $212,800 - $350,467	-48,474 Reduced 70.79%	19,998 $88,000
Q1 2021 May 17, 2021	SELL	$4.39 - $9.08 $55,801 - $115,415	-12,711 Reduced 15.66%	68,472 $497,000
Q4 2020 Feb 16, 2021	BUY	$3.86 - $5.07 $313,366 - $411,597	81,183 New	81,183 $351,000
Q3 2020 Nov 16, 2020	SELL	$4.11 - $6.45 $105,516 - $165,590	-25,673 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.75 - $11.99 $42,716 - $89,073	7,429 Added 40.72%	25,673 $154,000
Q1 2020 May 15, 2020	BUY	$5.65 - $15.71 $37,662 - $104,722	6,666 Added 57.57%	18,244 $137,000
Q4 2019 Feb 14, 2020	BUY	$10.15 - $15.58 $117,516 - $180,385	11,578 New	11,578 $159,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.